Emerging therapies for non-small cell lung cancer

Recent advances in the field of novel anticancer agents prolong patients’ survival and show a promising future. Tyrosine kinase inhibitors and immunotherapy for lung cancer are the two major areas undergoing rapid development. Although increasing novel anticancer agents were innovated, how to transl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chao, Leighl, Natasha B., Wu, Yi-Long, Zhong, Wen-Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482588/
https://www.ncbi.nlm.nih.gov/pubmed/31023335
http://dx.doi.org/10.1186/s13045-019-0731-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482588/
https://www.ncbi.nlm.nih.gov/pubmed/31023335
http://dx.doi.org/10.1186/s13045-019-0731-8

Ejemplares similares